心脑血管药理食管癌放疗增敏

上传人:cel****460 文档编号:243462386 上传时间:2024-09-23 格式:PPT 页数:52 大小:905KB
返回 下载 相关 举报
心脑血管药理食管癌放疗增敏_第1页
第1页 / 共52页
心脑血管药理食管癌放疗增敏_第2页
第2页 / 共52页
心脑血管药理食管癌放疗增敏_第3页
第3页 / 共52页
点击查看更多>>
资源描述
Click to edit Master title style,Click to edit Master text styles,Second Level,Third Level,Fourth Level,Fifth Level,Di Yan, DSc,William Beaumont Hospital,单击此处编辑母版标题样式,单击此处编辑母版文本样式,第二级,第三级,第四级,第五级,*,*,单击此处编辑母版标题样式,单击此处编辑母版文本样式,第二级,第三级,第四级,第五级,*,*,心脑血管药理食管癌放疗增敏,Radiotherapy Modalities,Fractionation,Normal, hyper, hypo, and simultaneous boost,Conformality,CRT, IMRT, CTV-to-PTV margin, dose distribution,High LET radiation,10 (n), 100 KeV/,m,m (p,a,),Sensitizers or biological modifiers,O,2, chemo, gene drug,Classic Radiobiology Framework,The biological basis for fractionation & total treatment time,Radiosensitivity of cell survival,Cell cycle kinetics (proliferation),DNA damage/repair (incomplete repair),The biological basis for conformality,Dose/volume effect,Molecular targeting,Radiocurability of 8-mm A431 tumor xenografts in nude mice. Radiation dose-response curves were generated for local tumor control at 120 days after treatment with radiation alone (open circle), a single dose of C225 plus radiation (open triangle), or three doses of C225 plus radiation (filled square). Error bars are 95% confidence intervals on the TCD,50.,Tumor or early reaction normal cell =,a/b,= 10,Late reaction normal cell =,a/b,= 3,Cell Survival During RT,Cell survival fraction (log) after one and n times dose delivery,Example: Tumor (,a/b,= 10),If,a,0.62 = TCP(35x2Gy) = 0% not curable,If,a,0.4, then,SF, TCP =100% always curable,Biologically Effective Dose (BED),The relationship between log cell killing and BED is always linear.,For a given dose per fraction, the BED is larger for late reacting tissue than tumor or early reacting tissue,To remain BED = constant:,Without considering cell proliferation and damage/repair,small fraction dose with large number of fractions seems,always good for normal tissues , meanwhile it remains,similar effect for tumor.,Rapid Repopulation of Tumor During RT,Tumor Cell Proliferation During RT,Tumor cell survival with consideration of tumor cell proliferation during the RT,Example: t,lag,= 21 days, t,pot,= 3 days and,a,= 0.3,a/b,= 10,After the first 21 days of treatment, the dose loss for one extra day is equals to 0.77 Gy,It implies that in the conventional RT (60 Gy = 30x2Gy week days), the equivalent dose is only 44 Gy,Biologically Effective Dose for Tumor with consideration of tumor cell proliferation during the RT,Incomplete Repair of Normal Tissue During RT,Incomplete Repair of Normal Tissue During RT,Example: t,rep,= 4 hrs, DT = 6 hrs,a,= 0.3,a/b,= 3,It implies that in the hyper-fractionation RT (60 Gy = 30x2Gy, two fractions per days), the equivalent dose will be 66.5 Gy,Biologically Effective Dose for a normal tissue with consideration of incomplete repair,Biological Equivalence:,Two dose fractionation regimens,(n,1, d,1,),and,(n,2, d,2,),are biologically equivalent with respect to tumor control or normal tissue complication if and only if,Normalized Total Dose (NTD): convert dose to NTD before applying conventional RT dose response for treatment evaluation,H&N: 3DCRT vs. 9 Beam IMRT (Dose-Volume Criteria),Cord,Tumor,Nodes,Parotids,Brainstem,3DCRT,IMRT,Lung: 3DCRT vs. 5 Beam IMRT,Heart,Esophagus,Lung,Spinal Cord,A specified dose- volume constraint can lead to an infinite number of dose responses,An infinite number of dose-volume histograms lead to the same response,Limitations of Dose-Volume-Based Treatment Planning Evaluation,Constraint: V(d 50 Gy) D - D,0,= (1/,)ln,/,0,.,Dose is relatively insensitive to the cells density.,Effect of Tumor Cells Density,(,= 0.4; D,0,= 60 Gy).,r,/,r,0,Density%,Dose%,0,D,0,= 60 Gy,TCP for Heterogeneous Dose Distribution,Tumor volume V =,N,0,; Considering V = V,1,+ V,2, and V,1,was irradiated with dose D,1,and V,2,with dose D,2,:TCP = exp(- N,s,),N,s,=,V,1,exp (-,D,1,) +,V,2,exp (-,D,2,),=,V,1,/ V) N,0,exp (-,D,1,) +,V,2,/ V) N,0,exp (-,D,2,),= ln(TCP) =,V,1,/V) lnTCP(V,D,1,) + (V,2,/V) lnTCP(V, D,2,),Therefore,85%of tumor volume has full dose, and the other 15% has dose deficiency of 0%, 10%, 15% or 20% respectively,TCP,Gy,dose deficiency in,15% of volume,- 0%,- 10%,- 15%,- 20%,Calculate TCP for 3D Treatment Planning Evaluation,Tumor volume has,DVH =(V,1, D,1,), (V,2, D,2,), ,In the practice, TCP(V, D,i,) is determined from,clinical dose response fitting,TCP for Adenocarcinoma of Prostate,Gy,TCP,TCD,50,g,50,Calculate TCP for 3D Treatment Planning Evaluation,Example (Prostate cancer):,V = V,1,+ V,2,; V,1,/V = 85%, V,2,/V = 15% ; V,1,with dose D,1,= 80 Gy and V,2,with dose D,2,= 72 Gy.,(TCP(V, 80 Gy) = 78% and TCP(V, 72 Gy) = 55%),Then,Summary,Two dose fractionation regimens or two dose distributions are equivalent if and only if the corresponding biological/clinical outcomes are equivalent,It is a mistake to believe that there is a simple “true model” in the biological sciences,However, they are all useful and necessary to guide us in clinical study and routine practice,谢谢观赏,
展开阅读全文
相关资源
正为您匹配相似的精品文档
相关搜索

最新文档


当前位置:首页 > 压缩资料 > 药学课件


copyright@ 2023-2025  zhuangpeitu.com 装配图网版权所有   联系电话:18123376007

备案号:ICP2024067431-1 川公网安备51140202000466号


本站为文档C2C交易模式,即用户上传的文档直接被用户下载,本站只是中间服务平台,本站所有文档下载所得的收益归上传人(含作者)所有。装配图网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。若文档所含内容侵犯了您的版权或隐私,请立即通知装配图网,我们立即给予删除!